Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data

Journal of the American College of Cardiology
Kevin DammanJohn J V McMurray

Abstract

Chronic kidney disease (CKD) is increasingly prevalent in patients with chronic systolic heart failure. Therefore, evidence-based therapies are more and more being used in patients with some degree of renal dysfunction. However, most pivotal randomized clinical trials specifically excluded patients with (severe) renal dysfunction. The benefit of these evidence-based therapies in this high-risk patient group is largely unknown. This paper reviews data from randomized clinical trials in systolic heart failure and the interactions between baseline renal dysfunction and the effect of randomized treatment. It highlights that most evidence-based therapies show consistent outcome benefit in patients with moderate renal insufficiency (stage 3 CKD), whereas there are very scarce data on patients with severe (stage 4 to 5 CKD) renal insufficiency. If any, the outcome benefit might be even greater in stage 3 CKD compared with those with relatively preserved renal function. However, prescription of therapies should be individualized with consideration of possible harm and benefit, especially in those with stage 4 to 5 CKD where limited data are available.

References

Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Dec 31, 1997·The New England Journal of Medicine·UNKNOWN Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Sep 19, 2000·Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology·P Della Bella
Mar 22, 2002·The New England Journal of Medicine·Arthur J MossUNKNOWN Multicenter Automatic Defibrillator Implantation Trial II Investigators
Jun 14, 2002·The New England Journal of Medicine·William T AbrahamUNKNOWN MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation
Aug 9, 2002·European Journal of Heart Failure·Juan CosínUNKNOWN TORIC investigators
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
May 14, 2003·Journal of the American College of Cardiology·Gennaro CiceRaffaele Calabrò
Jun 5, 2003·Annals of Internal Medicine·Michael G Shlipak
Nov 12, 2003·The New England Journal of Medicine·Marc A PfefferUNKNOWN Valsartan in Acute Myocardial Infarction Trial Investigators
May 21, 2004·The New England Journal of Medicine·Alan KadishUNKNOWN Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators
Jul 31, 2004·Journal of the American Society of Nephrology : JASN·Michael G ShlipakHarlan M Krumholz
Sep 24, 2004·The New England Journal of Medicine·Alan S GoChi-yuan Hsu
Mar 9, 2005·The New England Journal of Medicine·John G F ClelandUNKNOWN Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators
Feb 8, 2006·Circulation·Hans L HillegeDirk J van Veldhuisen
Aug 9, 2006·The American Journal of Cardiology·Ilan GoldenbergUNKNOWN Multicenter Automatic Defibrillator Implantation Trial-II Investigators
Feb 6, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN KDOQI
Oct 10, 2007·Journal of Cardiac Failure·Kevin DammanHans L Hillege
Jan 5, 2008·International Journal of Clinical Practice·G Jackson
Nov 15, 2008·Journal of the American College of Cardiology·Claudio RoncoRinaldo Bellomo
May 1, 2009·Gene Therapy·S W J McPhee, R J Samulski
Aug 4, 2009·European Journal of Heart Failure·Alain Cohen-SolalUNKNOWN SENIORS Investigators
Aug 18, 2009·Lancet·Colette E JacksonUNKNOWN CHARM Investigators and Committees
Sep 3, 2009·The New England Journal of Medicine·Arthur J MossUNKNOWN MADIT-CRT Trial Investigators

❮ Previous
Next ❯

Citations

Dec 3, 2014·The American Journal of Cardiology·Chakradhari InampudiAli Ahmed
Apr 4, 2015·European Heart Journal·Kevin Damman, Jeffrey M Testani
May 12, 2016·Medizinische Klinik, Intensivmedizin und Notfallmedizin·U Janssens, M Joannidis
Nov 26, 2016·Heart Failure Clinics·Jeremy A Mazurek, Mariell Jessup
Mar 11, 2017·Current Heart Failure Reports·Elizabeth Riddell, Justin M Vader
Mar 12, 2019·Circulation·Janani RangaswamiUNKNOWN American Heart Association Council on the Kidney in Cardiovascular Disease and Council on Clinical Cardiology
Nov 30, 2019·Circulation Journal : Official Journal of the Japanese Circulation Society·Hyun-Jin KimKyu-Hyung Ryu
Jan 23, 2020·Heart Failure Reviews·Wolfgang KruegerMaciej Henneberg
Nov 9, 2019·Heart Failure Reviews·Gaetano RuoccoJozine M Ter Maaten
Feb 28, 2020·The Cochrane Database of Systematic Reviews·Meaghan LunneyPietro Ravani
Sep 2, 2020·Journal of Nephrology·Giacomo DeferrariEdoardo La Porta
Jul 17, 2015·Pacing and Clinical Electrophysiology : PACE·Gaurav SingalTheofanie Mela
Mar 7, 2019·European Heart Journal Supplements : Journal of the European Society of Cardiology·Shilpa VijayakumarGeorge L Bakris
Sep 11, 2020·Current Cardiology Reports·W H Wilson Tang, Alan Kiang
May 3, 2016·European Journal of Heart Failure·Uwe PrimessnigFrank R Heinzel
Sep 14, 2017·British Journal of Clinical Pharmacology·Ahmed Al-NaherMunir Pirmohamed
Jan 20, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kenichi MatsushitaHideaki Yoshino
Oct 2, 2019·Diabetology & Metabolic Syndrome·Alaaeldin BashierRobert Chilton
Jun 8, 2021·Clinical Kidney Journal·Felix Perez-VillaÀngel Argilés
Jun 27, 2021·European Journal of Heart Failure·Amr Abdin, Michael Böhm
Aug 28, 2021·European Heart Journal·Theresa A McDonaghUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.